George C. Petrocheilos

Co-Founder & Managing Partner at Catalio Capital Management

View Live Interactive Profile →

Biography

George C. Petrocheilos is Co-Founder and Managing Partner of Catalio Capital Management, LP. The firm's team page states that he is primarily responsible for managing the firm and for making investments in private innovative healthcare companies, and that he serves on Catalio investment and management committees. He holds a B.A. in Financial Economics from Johns Hopkins University and was previously a General Partner at Camden Partners Holdings, LLC. He was President of HealthCor Catalio Acquisition Corp. (Nasdaq: HCAQ). His firm biography also lists board experience at Haystack Oncology, Octant Bio, DNA Script, Clasp Therapeutics and Odyssey Therapeutics; of these only Fond of You, Inc. could be confirmed from a first-party issuer filing, and the Odyssey Therapeutics claim is not corroborated by any Odyssey SEC filing, so the unconfirmed seats are recorded in notes rather than in boardSeats.

Education

Previous Experience

Notable Investments

Entera Bio Ltd. ENTXFond of You, Inc.

Board Seats

Career Timeline

2020
Co-founds Catalio Capital Management with R. Jacob Vogelstein.
2026
Named as a Director of Fond of You, Inc. in the issuer's Form D filed 4 March 2026.
2026
Named, with R. Jacob Vogelstein, as having voting or investment control over the Entera Bio shares held by Catalio Nexus and Catalio BH SPV, LLC in Entera Bio's 28 August 2026 resale prospectus.

Sources & References

Catalio Capital Management - Team (roster verified across four passes, 7 Sep 2026) ↗Catalio - George C. Petrocheilos ↗SEC EDGAR - Fond of You, Inc. Form D (4 March 2026) ↗SEC EDGAR - Entera Bio Ltd. Rule 424(b)(3) prospectus (28 August 2026) ↗